Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.
Copyright 2024 – Finance News Network
Source: Finance News Network
08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
Read More07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
Read More02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
Read More13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More10 Oct 2023 - Tara French - Managing Director - Cazaly Resources (ASX:CAZ) is a Perth based Australian diversified mineral exploration and resource development company.
Read More20 Sep 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the FDA's award of orphan status and rare paediatric disease designation for the company's DUNP19 technology.
Read More29 Aug 2024 - Corella Resources Limited (ASX:CR9) CEO Jess Maddren provides an overview of the business, discussing novel steps for high-purity alumina flowsheeting.
Read More08 May 2023 - Empire Energy Group Limited (ASX:EEG) Managing Director Alex Underwood discusses NT Government approval for fracking in the Beetaloo Basin, exemptions for small producers, traditional owners, pipelines, government funding and the company's pilot project.
Read More23 Sep 2019 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director & CEO, Stephen Carter discusses the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa.
Read More
